Skip to main content

Table 1 Input parameters used in economic model

From: The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, Iran

Variable

Mean

SD

Distribution

Source

Prob NRH to NRH

0.168

0.37

Beta

Göhler et al. [30]

Prob NRH to D

0.067

0.24

Beta

Göhler et al. [30]

Prob RH1 to RH1

0.213

0.36

Beta

Göhler et al. [30]

Prob RH1 to D

0.075

0.025

Beta

Göhler et al. [30]

Prob RH2 to RH2

0.268

0.37

Beta

Göhler et al. [30]

Prob RH2 to D

0.085

0.32

Beta

Göhler et al. [30]

Prob RH3 to D

0.095

0.33

Beta

Göhler et al. [30]

RR

0.81

5

LN

Pufulete et al. [16]

CostNRH_B

$309

67

Gamma

Calculated

Cost RH1_B

$446

100

Gamma

Calculated

Cost RH2_B

$585

175

Gamma

Calculated

Cost RH3_B

$861

249

Gamma

Calculated

Cost NRH_CA

$272

65

Gamma

Calculated

Cost RH1_CA

$548

153

Gamma

Calculated

Cost RH2_CA

$824

247

Gamma

Calculated

Cost RH3_CA

$1100

341

Gamma

Calculated

Utility NRH

0.85

0.23

Beta

Calculated

Utility RH1

0.828

0.25

Beta

Calculated

Utility RH2

0.809

0.26

Beta

Calculated

Utility RH3

0.777

0.24

Beta

Calculated

  1. SD, standard deviation; Prob, probability; NRH, no rehospitalization; RH1, rehospitalization 1; RH2, rehospitalization 2; RH3, rehospitalization3; B, B-type natriuretic peptide (BNP); CA, clinical assessment; RR, relative risk; LN, Log-Normal